Display options
Share it on

Front Immunol. 2017 Mar 31;8:287. doi: 10.3389/fimmu.2017.00287. eCollection 2017.

The Spontaneous Autoimmune Neuromyopathy in ICOSL.

Frontiers in immunology

Claire Briet, Gwladys Bourdenet, Ute C Rogner, Chantal Becourt, Isabelle Tardivel, Laurent Drouot, Christophe Arnoult, Jean-Claude do Rego, Nicolas Prevot, Charbel Massaad, Olivier Boyer, Christian Boitard

Affiliations

  1. INSERM U1016, Cochin Institute, Paris Descartes University, Sorbonne Paris Cité, Paris, France.
  2. Normandie Université, UNIROUEN, INSERM, U1234, Rouen University Hospital, Department of Immunology, Rouen, France.
  3. INSERM U1016, Cochin Institute, Paris, France.
  4. Normandie Université, UNIROUEN, CNRS, UMR 6270, Rouen, France.
  5. Normandie Université, UNIROUEN, SCAC, INSERM, U1234, Rouen, France.
  6. Developmental Immunology, Department of Paediatrics, and the Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.
  7. INSERM UMR S1124, Paris Descartes University, Paris, France.

PMID: 28424681 PMCID: PMC5371727 DOI: 10.3389/fimmu.2017.00287

Abstract

Abrogation of ICOS/ICOS ligand (ICOSL) costimulation prevents the onset of diabetes in the non-obese diabetic (NOD) mouse but, remarkably, yields to the development of a spontaneous autoimmune neuromyopathy. At the pathological level, ICOSL

Keywords: ICOS; ICOSL; autoimmunity; costimulation; myopathy; neuropathy; type 1 diabetes

References

  1. J Autoimmun. 1998 Dec;11(6):603-10 - PubMed
  2. Diabetologia. 1993 Aug;36(8):716-21 - PubMed
  3. J Exp Med. 1996 Jan 1;183(1):67-76 - PubMed
  4. Cell Immunol. 1999 Mar 15;192(2):113-21 - PubMed
  5. Nat Rev Endocrinol. 2015 May;11(5):308-14 - PubMed
  6. Immunity. 1996 Sep;5(3):285-93 - PubMed
  7. Eur J Immunol. 1992 Sep;22(9):2387-93 - PubMed
  8. J Immunol. 2004 Aug 15;173(4):2315-23 - PubMed
  9. J Immunol. 2009 Oct 1;183(7):4147-9 - PubMed
  10. Scand J Immunol. 2005 Feb;61(2):119-27 - PubMed
  11. Expert Opin Biol Ther. 2005 Sep;5 Suppl 1:S61-71 - PubMed
  12. Autoimmunity. 2002 Aug;35(5):329-33 - PubMed
  13. Science. 2001 Jan 12;291(5502):319-22 - PubMed
  14. Nat Med. 2003 Feb;9(2):198-205 - PubMed
  15. Immunology. 1994 Oct;83(2):227-31 - PubMed
  16. J Immunol. 1996 Oct 15;157(8):3688-93 - PubMed
  17. J Autoimmun. 2013 Sep;45:58-67 - PubMed
  18. Eur J Immunol. 2002 Sep;32(9):2687-97 - PubMed
  19. Annu Rev Immunol. 2001;19:225-52 - PubMed
  20. J Immunol. 2008 Mar 1;180(5):3140-7 - PubMed
  21. Biomed Pharmacother. 1993;47(1):3-10 - PubMed
  22. Immunol Res. 2014 May;58(2-3):340-50 - PubMed
  23. J Endocrinol. 1991 Nov;131(2):193-6 - PubMed
  24. Exp Clin Endocrinol Diabetes. 1996;104 Suppl 3:17-20 - PubMed
  25. J Exp Med. 2009 Mar 16;206(3):507-14 - PubMed
  26. Nat Med. 2003 Dec;9(12):1477-83 - PubMed
  27. Adv Exp Med Biol. 2002;506(Pt B):1035-9 - PubMed
  28. J Exp Med. 2003 Nov 17;198(10):1527-37 - PubMed
  29. Eur J Immunol. 2010 Aug;40(8):2267-76 - PubMed
  30. Adv Immunol. 2008;100:151-75 - PubMed
  31. Immunity. 2000 Apr;12(4):431-40 - PubMed
  32. Brain. 2003 May;126(Pt 5):1026-35 - PubMed
  33. Nature. 1990 Jun 21;345(6277):724-6 - PubMed
  34. Proc Natl Acad Sci U S A. 1997 Aug 5;94(16):8670-4 - PubMed
  35. Int Immunol. 2009 May;21(5):499-509 - PubMed
  36. Immunol Rev. 2009 May;229(1):41-66 - PubMed
  37. Eur J Immunol. 1993 Dec;23(12):3358-60 - PubMed
  38. J Immunol. 1999 Apr 15;162(8):4576-88 - PubMed
  39. Cold Spring Harb Perspect Med. 2012 Jul;2(7):a007690 - PubMed
  40. Proc Natl Acad Sci U S A. 1988 Dec;85(24):9719-23 - PubMed
  41. Diabetes. 2005 Dec;54 Suppl 2:S87-96 - PubMed
  42. Adv Immunol. 1992;51:285-322 - PubMed
  43. Genome Res. 2000 Apr;10(4):446-53 - PubMed
  44. Scand J Immunol. 2003 Mar;57(3):203-13 - PubMed
  45. Annu Rev Immunol. 2005;23:447-85 - PubMed

Publication Types